Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome

Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome

The purpose of this study is to compare the efficacy and safety of T2762 versus Optive® in the treatment of moderate to severe Dry Eye Syndrome.

Inclusion Criteria:

• Signed and dated informed consent.
• Male or female aged ≥ 18 years old.
• Diagnosis of moderate to severe dry eye syndrome

Exclusion Criteria:

• Pregnancy, lactation.
• Childbearing potential woman who is not using a reliable method of contraception and is not surgically sterilised.
• Inability of patient to understand the study procedures and thus inability to give informed consent.
• Non-compliant patient
• Participation in another clinical study at the same time as the present study.
• Participation to the present study during the exclusion period of another clinical study.
• Already included once in this study.
• Ward of court.
• Patient not covered by government health care scheme